Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 4:52 PM View:  | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 26-Mar-24 | Payment of Exercise | 114 | $128.11 | $14,604.50 | (< 1%) 16.09K to 15.98K | |
| 28-Mar-24 4:52 PM View: | Delaney Mark E SVP & Chief Commercial Officer | Quest Diagnostics Inc. (DGX) | 26-Mar-24 | Payment of Exercise | 170 | $128.11 | $21,778.70 | (3%) 5.6K to 5.43K | |
| 01-Mar-24 4:51 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 29-Feb-24 | Sale (Planned) | 1,187 | $125.88 | $149,420.00 | (2%) 73.95K to 72.76K | |
| 01-Mar-24 4:50 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 29-Feb-24 | Sale (Planned) | 5,611 | $125.88 | $706,313.00 | (11%) 49.63K to 44.02K | |
| 01-Mar-24 4:44 PM View: | Davis J. E. CEO and President Director | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 5,020 | $126.36 | $634,327.00 | (4%) 130.99K to 125.97K | |
| 01-Mar-24 4:51 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 1,201 | $126.36 | $151,758.00 | (1%) 80.71K to 79.5K | |
| 01-Mar-24 4:46 PM View: | Samad Samer Abdul Executive Vice President & CFO | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 656 | $126.36 | $82,892.20 | (3%) 21.99K to 21.33K | |
| 01-Mar-24 4:43 PM View: | Gardner Mark A SVP of Molecular Gen & Oncol | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 262 | $126.36 | $33,106.30 | (5%) 5.05K to 4.79K | |
| 01-Mar-24 4:49 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 273 | $126.36 | $34,496.30 | (2%) 17.27K to 17.0K | |
| 01-Mar-24 4:50 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 861 | $126.36 | $108,796.00 | (2%) 50.49K to 49.63K | |
| 01-Mar-24 4:41 PM View: | Delaney Mark E SVP & Chief Commercial Officer | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 225 | $126.36 | $28,431.00 | (4%) 5.83K to 5.6K | |
| 01-Mar-24 4:42 PM View: | Deppe Michael J SVP, Corp. Controller & CAO | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 109 | $126.36 | $13,773.20 | (< 1%) 35.72K to 35.61K | |
| 01-Mar-24 4:55 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Payment of Exercise | 333 | $126.36 | $42,077.90 | (2%) 16.41K to 16.08K | |
| 01-Mar-24 4:51 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 28-Feb-24 | Sale (Planned) | 5,557 | $126.57 | $703,350.00 | (7%) 79.5K to 73.95K | |
| 27-Feb-24 4:32 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 619 | $125.02 | $77,387.40 | (3%) 17.89K to 17.27K | |
| 27-Feb-24 4:35 PM View: | Davis J. E. CEO and President Director | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 13,390 | $125.02 | $1,674,020.00 | 11% 124.12K to 137.51K | |
| 27-Feb-24 4:33 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 9,314 | $125.02 | $1,164,440.00 | 12% 75.15K to 84.46K | |
| 27-Feb-24 4:34 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 2,825 | $125.02 | $353,182.00 | (5%) 53.32K to 50.49K | |
| 23-Feb-24 4:34 PM View: | Gregg Vicky B Director | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Sale | 2,500 | $126.64 | $316,596.00 | (13%) 18.83K to 16.33K | |
| 27-Feb-24 4:32 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 2,039 | $125.02 | $254,916.00 | 13% 15.85K to 17.89K | |
| 27-Feb-24 4:31 PM View: | Deppe Michael J SVP, Corp. Controller & CAO | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 631 | $125.02 | $78,887.60 | (2%) 36.35K to 35.72K | |
| 27-Feb-24 4:34 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 7,569 | $125.02 | $946,276.00 | 17% 45.75K to 53.32K | |
| 27-Feb-24 4:33 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 869 | $125.02 | $108,642.00 | (5%) 17.28K to 16.41K | |
| 27-Feb-24 4:31 PM View: | Deppe Michael J SVP, Corp. Controller & CAO | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 1,689 | $125.02 | $211,159.00 | 5% 34.66K to 36.35K | |
| 27-Feb-24 4:35 PM View: | Davis J. E. CEO and President Director | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 6,525 | $125.02 | $815,756.00 | (5%) 137.51K to 130.99K | |
| 27-Feb-24 4:33 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Grant | 2,388 | $125.02 | $298,548.00 | 16% 14.9K to 17.28K | |
| 27-Feb-24 4:33 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 23-Feb-24 | Payment of Exercise | 3,757 | $125.02 | $469,700.00 | (4%) 84.46K to 80.71K | |
| 23-Feb-24 4:35 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 22-Feb-24 | Sale (Planned) | 661 | $126.14 | $83,378.50 | (1%) 46.41K to 45.75K | |
| 23-Feb-24 4:32 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 22-Feb-24 | Sale (Planned) | 821 | $126.14 | $103,561.00 | (1%) 75.97K to 75.15K | |
| 23-Feb-24 4:31 PM View: | Deppe Michael J SVP, Corp. Controller & CAO | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 89 | $125.02 | $11,126.80 | (< 1%) 34.07K to 33.98K | |
| 23-Feb-24 4:37 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 139 | $125.02 | $17,377.80 | (< 1%) 15.04K to 14.9K | |
| 23-Feb-24 4:35 PM View: | Davis J. E. CEO and President Director | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 762 | $125.02 | $95,265.20 | (< 1%) 124.89K to 124.12K | |
| 23-Feb-24 4:32 PM View: | Doherty Catherine T. EVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 493 | $125.02 | $61,634.90 | (< 1%) 76.46K to 75.97K | |
| 23-Feb-24 4:33 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 102 | $125.02 | $12,752.00 | (< 1%) 15.95K to 15.85K | |
| 23-Feb-24 4:35 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 21-Feb-24 | Payment of Exercise | 407 | $125.02 | $50,883.10 | (< 1%) 46.81K to 46.41K | |
| 16-Feb-24 8:03 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 2,641 | -- | -- | 20% 13.3K to 15.95K | |
| 16-Feb-24 8:04 PM View: | Prevoznik Michael E SVP & General Counsel | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 2,935 | -- | -- | 7% 43.88K to 46.81K | |
| 16-Feb-24 8:02 PM View: | Delaney Mark E SVP & Chief Commercial Officer | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 2,348 | -- | -- | 67% 3.48K to 5.83K | |
| 16-Feb-24 8:01 PM View: | Deppe Michael J SVP, Corp. Controller & CAO | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 558 | -- | -- | 2% 34.19K to 34.75K | |
| 16-Feb-24 8:04 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 2,446 | -- | -- | 19% 12.59K to 15.04K | |
| 16-Feb-24 8:06 PM View: | Davis J. E. CEO and President Director | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 22,251 | -- | -- | 22% 102.63K to 124.89K | |
| 16-Feb-24 8:01 PM View: | Doherty Catherine T. SVP, Regional Businesses | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 4,304 | -- | -- | 6% 72.16K to 76.46K | |
| 16-Feb-24 8:03 PM View: | Samad Samer Abdul Executive Vice President & CFO | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 5,478 | -- | -- | 33% 16.51K to 21.99K | |
| 16-Feb-24 8:05 PM View: | Gardner Mark A SVP of Molecular Gen & Oncol | Quest Diagnostics Inc. (DGX) | 14-Feb-24 | Grant | 2,250 | -- | -- | 80% 2.81K to 5.05K | |
| 02-Feb-24 4:34 PM View: | Plewman Patrick SVP for Diagnostic Services | Quest Diagnostics Inc. (DGX) | 31-Jan-24 | Grant | 50 | $129.33 | $6,466.30 | < 1% 12.54K to 12.59K | |
| 02-Feb-24 4:38 PM View: | Samad Samer Abdul Executive Vice President & CFO | Quest Diagnostics Inc. (DGX) | 31-Jan-24 | Grant | 17 | $129.33 | $2,198.56 | < 1% 16.49K to 16.51K | |
| 02-Feb-24 4:37 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 31-Jan-24 | Grant | 29 | $129.33 | $3,750.45 | < 1% 13.27K to 13.3K | |
| 02-Feb-24 4:40 PM View: | Gregg Vicky B Director | Quest Diagnostics Inc. (DGX) | 31-Jan-24 | Grant | 88 | $129.33 | $11,380.80 | < 1% 18.74K to 18.83K | |
| 26-Oct-23 6:15 PM View: | Samad Samer Abdul Executive Vice President & CFO | Quest Diagnostics Inc. (DGX) | 23-Oct-23 | Grant | 18 | $122.86 | $2,211.55 | < 1% 16.48K to 16.49K | |
| 26-Oct-23 6:17 PM View: | Kuppusamy Karthik SVP, Clinical Solutions | Quest Diagnostics Inc. (DGX) | 23-Oct-23 | Grant | 30 | $122.86 | $3,685.86 | < 1% 13.17K to 13.2K |
